Shilai Li

563 total citations
11 papers, 406 citations indexed

About

Shilai Li is a scholar working on Molecular Biology, Pharmacology and Surgery. According to data from OpenAlex, Shilai Li has authored 11 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pharmacology and 2 papers in Surgery. Recurrent topics in Shilai Li's work include Drug-Induced Hepatotoxicity and Protection (3 papers), Heme Oxygenase-1 and Carbon Monoxide (2 papers) and Pharmacological Effects of Natural Compounds (2 papers). Shilai Li is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (3 papers), Heme Oxygenase-1 and Carbon Monoxide (2 papers) and Pharmacological Effects of Natural Compounds (2 papers). Shilai Li collaborates with scholars based in China and United States. Shilai Li's co-authors include Chenxuan Yang, Patricia Loughran, Melanie J. Scott, Meihong Deng, Timothy R. Billiar, Zhongjie Yi, Ping Sun, Lei Zhao, Guang Fu and Feizhou Huang and has published in prestigious journals such as Hepatology, Frontiers in Immunology and Cell Death and Disease.

In The Last Decade

Shilai Li

11 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shilai Li China 8 214 118 95 45 43 11 406
Huimin Xian China 4 270 1.3× 48 0.4× 116 1.2× 65 1.4× 14 0.3× 7 448
Cunzao Wu China 11 253 1.2× 36 0.3× 96 1.0× 61 1.4× 82 1.9× 19 474
Emily Huang United States 9 243 1.1× 71 0.6× 232 2.4× 47 1.0× 42 1.0× 15 556
Roger Flores‐Costa Spain 13 168 0.8× 68 0.6× 264 2.8× 101 2.2× 159 3.7× 19 581
Xingmei Yao China 13 188 0.9× 28 0.2× 102 1.1× 44 1.0× 26 0.6× 25 475
Trinidad Parra Spain 8 89 0.4× 58 0.5× 54 0.6× 44 1.0× 81 1.9× 10 391
Yujie Qiao China 9 159 0.7× 45 0.4× 144 1.5× 25 0.6× 12 0.3× 17 396
Huimin Gu China 10 191 0.9× 39 0.3× 78 0.8× 35 0.8× 25 0.6× 21 492
Marwa Mohamed Atef Egypt 13 161 0.8× 31 0.3× 49 0.5× 41 0.9× 14 0.3× 29 383
Marta Duran‐Güell Spain 14 151 0.7× 50 0.4× 271 2.9× 94 2.1× 166 3.9× 20 558

Countries citing papers authored by Shilai Li

Since Specialization
Citations

This map shows the geographic impact of Shilai Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shilai Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shilai Li more than expected).

Fields of papers citing papers by Shilai Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shilai Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shilai Li. The network helps show where Shilai Li may publish in the future.

Co-authorship network of co-authors of Shilai Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shilai Li. A scholar is included among the top collaborators of Shilai Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shilai Li. Shilai Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Wang, He, et al.. (2022). TSLP protects against sepsis-induced liver injury by inducing autophagy via activation of the PI3K/Akt/STAT3 pathway. Pathology - Research and Practice. 236. 153979–153979. 10 indexed citations
2.
Pan, Ling, Shilai Li, Yu‐Zhen Luo, et al.. (2021). Coagulation parameters may predict clinical outcomes in patients with septic acute kidney injury. Clinical Nephrology. 96(5). 253–262. 12 indexed citations
3.
Li, Shilai, Ling Pan, Wenhui Pan, et al.. (2021). Potential protective effect of hesperidin on hypoxia/reoxygenation‑induced hepatocyte injury. Experimental and Therapeutic Medicine. 22(1). 764–764. 7 indexed citations
4.
Li, Wenbo, Meihong Deng, Patricia Loughran, et al.. (2020). LPS Induces Active HMGB1 Release From Hepatocytes Into Exosomes Through the Coordinated Activities of TLR4 and Caspase-11/GSDMD Signaling. Frontiers in Immunology. 11. 229–229. 113 indexed citations
5.
Yi, Zhongjie, Meihong Deng, Melanie J. Scott, et al.. (2020). Immune‐Responsive Gene 1/Itaconate Activates Nuclear Factor Erythroid 2–Related Factor 2 in Hepatocytes to Protect Against Liver Ischemia–Reperfusion Injury. Hepatology. 72(4). 1394–1411. 147 indexed citations
6.
Li, Shilai, Wenhui Pan, Yuqing Wei, et al.. (2020). IL‑17 is a potential biomarker for predicting the severity and outcomes of pulmonary contusion in trauma patients. Biomedical Reports. 14(1). 1–1. 3 indexed citations
7.
Li, Shilai, et al.. (2020). Hesperidin ameliorates liver ischemia/reperfusion injury via activation of the Akt pathway. Molecular Medicine Reports. 22(6). 4519–4530. 21 indexed citations
8.
Li, Shilai, Zhongjie Yi, Meihong Deng, et al.. (2019). TSLP protects against liver I/R injury via activation of the PI3K/Akt pathway. JCI Insight. 4(22). 31 indexed citations
9.
Xu, Yansong, et al.. (2019). Epidemiological analysis of traumatic cervical spinal cord injury. Zhonghua jizhen yixue zazhi. 28(1). 84–89. 1 indexed citations
10.
Yang, Chenxuan, Ping Sun, Meihong Deng, et al.. (2019). Gasdermin D protects against noninfectious liver injury by regulating apoptosis and necroptosis. Cell Death and Disease. 10(7). 481–481. 43 indexed citations
11.
Li, Shilai, Tao Peng, Kaiyin Xiao, et al.. (2016). Associations between sequence variations in the mitochondrial DNA D-loop region and outcome of hepatocellular carcinoma. Oncology Letters. 11(6). 3723–3728. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026